Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Por um escritor misterioso
Descrição
Dupilumab leads to better-controlled asthma and quality of life in
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Dupixent (dupilumab) for the Treatment of Atopic Dermatitis, US
FDA Accepts Dupixent® (dupilumab) for Priority Review in Children
IL-4/13 blocker successful in treatment of paediatric moderate-to
Type 2 asthma in children managed by dupilumab, despite atopic
DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis
Dupilumab and tezepelumab in severe refractory asthma: new
Dupilumab reduces corticosteroid burdens among children with asthma
Dupilumab add-on therapy decreases exacerbations in moderate-to
de
por adulto (o preço varia de acordo com o tamanho do grupo)
